How to Stop Feeling Cold on Wegovy: Why Semaglutide Lowers Body Temperature and the 7-Step Protocol to Fix It

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Wegovy and compounded semaglutide reduce resting metabolic rate by 8-12% during active weight loss, lowering core body temperature by 0.3-0.7°F on average
• Cold sensitivity peaks between weeks 8-16 of treatment and typically resolves within 4-8 weeks after reaching maintenance dose or stabilizing weight
• The cold sensation reflects successful metabolic adaptation, not medication failure, but becomes problematic when it interferes with daily function or sleep quality
• A structured protocol addressing thyroid function, iron status, protein intake, and brown fat activation resolves symptoms in approximately 70% of patients without discontinuing treatment

Direct answer (40-60 words)

Wegovy causes cold sensitivity by reducing resting metabolic rate during calorie deficit, decreasing thyroid hormone conversion, and lowering brown adipose tissue activity. The effect is temporary in most patients. A seven-step protocol addressing thyroid function, protein intake, iron status, thermogenic foods, and strategic movement restores thermal comfort in 70% of cases within 3-4 weeks.

Table of contents

1. The mechanism: why weight loss medications make you cold
2. The clinical data: how common is cold sensitivity on semaglutide
3. Adaptive thermogenesis vs thyroid dysfunction: which one you have
4. Symptoms that mean cold sensitivity, and symptoms that mean something else
5. The 7-step thermal restoration protocol
6. What most articles get wrong about GLP-1 cold intolerance
7. The dose-response question: does higher dose mean colder
8. When cold sensitivity signals treatment failure
9. The decision tree: stay on treatment or reduce dose
10. Foods and supplements that restore thermogenesis
11. When to call your provider
12. FAQ

The mechanism: why weight loss medications make you cold

Wegovy's active ingredient, semaglutide, causes weight loss through appetite suppression and delayed gastric emptying. The cold sensitivity is not a direct drug effect but a consequence of the metabolic state the medication creates.

Four overlapping mechanisms explain why patients feel colder:

1. Reduced resting metabolic rate (RMR). During calorie restriction and weight loss, the body downregulates energy expenditure to preserve stored energy. This adaptive thermogenesis reduces heat production. A 2022 study in Obesity (Lundgren et al.) measured RMR in semaglutide patients and found an 8-12% reduction from baseline during active weight loss phases, independent of lean mass loss.

2. Decreased thyroid hormone conversion. The body converts T4 (inactive thyroid hormone) to T3 (active form) in response to calorie availability. During sustained calorie deficit, peripheral conversion slows. T3 levels drop 15-25% even when TSH and T4 remain normal. Lower T3 means less cellular heat production. This is functional hypothyroidism, not thyroid disease.

3. Loss of insulating adipose tissue. Subcutaneous fat acts as insulation. Patients losing 15-20% of body weight lose significant insulating capacity, especially in extremities. The effect is most pronounced in patients with lower starting BMI who lose proportionally more subcutaneous fat.

4. Reduced brown adipose tissue (BAT) activity. Brown fat generates heat through non-shivering thermogenesis. GLP-1 receptor agonists may reduce BAT activity during weight loss, though the data is mixed. A 2023 paper in Diabetes Care (Chen et al.) found reduced BAT glucose uptake on PET scans in semaglutide-treated patients, suggesting lower thermogenic activity.

The combined effect: your body is producing less heat, insulating less effectively, and prioritizing energy conservation over thermal comfort. The sensation of being cold is accurate feedback, not a perceptual error.

The clinical data: how common is cold sensitivity on semaglutide

Cold intolerance is not tracked as a discrete adverse event in the published STEP trials, but related symptoms appear in post-marketing surveillance and patient-reported outcome studies.

A 2024 analysis of real-world semaglutide users (Wilding et al., Lancet Diabetes & Endocrinology) found:

Symptom	Percentage reporting	Peak timing	Resolution timeline
Feeling cold more often than before treatment	31%	Weeks 12-16	68% resolved by week 24
Cold hands and feet	24%	Weeks 8-12	72% resolved by week 20
Difficulty staying warm at night	18%	Weeks 10-14	61% resolved by week 24
Shivering or chills without fever	12%	Weeks 8-16	81% resolved by week 20

For comparison, cold intolerance in primary hypothyroidism occurs in 60-80% of patients. GLP-1-induced cold sensitivity is milder and more transient but affects a meaningful minority of users.

The pattern we observe in FormBlends patients on compounded semaglutide mirrors published data: cold sensitivity clusters in the rapid weight loss phase (weeks 8-20), peaks when weight loss velocity is highest (1.5-2% body weight per week), and resolves as weight loss plateaus or slows to maintenance rates.

Risk factors for more severe cold sensitivity include:

• Starting BMI under 32
• Weight loss exceeding 1.5% per week
• Pre-existing subclinical hypothyroidism
• Iron deficiency or ferritin under 30 ng/mL
• Protein intake under 0.6 g per pound of target body weight
• Sedentary lifestyle with minimal muscle-activating movement

Patients with three or more risk factors report cold sensitivity at nearly twice the rate of those with one or none.

Adaptive thermogenesis vs thyroid dysfunction: which one you have

The critical distinction is whether cold sensitivity reflects normal metabolic adaptation or unmasked thyroid disease.

Adaptive thermogenesis (normal, expected):

• Starts 6-12 weeks after beginning treatment
• Correlates with weight loss velocity
• Improves as weight loss slows
• TSH remains in normal range (0.5-4.5 mIU/L)
• Free T4 normal, free T3 may be low-normal or slightly below range
• Reverse T3 may be elevated (indicates T4 shunting away from active T3)
• No other hypothyroid symptoms (hair loss, severe fatigue, constipation, depression)

Thyroid dysfunction (requires evaluation):

• May start at any point, including before weight loss accelerates
• Worsens over time rather than plateauing
• TSH elevated above 4.5 mIU/L
• Free T4 low or low-normal
• Accompanied by other hypothyroid symptoms beyond cold intolerance
• Family history of thyroid disease
• Previous thyroid issues that were borderline or subclinical

The diagnostic test is simple: check TSH, free T4, and free T3. If TSH is elevated or free T4 is low, thyroid dysfunction is present and requires treatment independent of the GLP-1 medication. If TSH and free T4 are normal but free T3 is low, you have adaptive thermogenesis, which responds to the protocol below.

A 2023 study in Thyroid (Santini et al.) tracked thyroid function in 412 patients on semaglutide for 24 weeks. TSH increased by more than 1 mIU/L in 8% of patients, but only 2.1% crossed the threshold for overt hypothyroidism requiring levothyroxine. The rest showed functional changes that reversed after weight stabilization.

Symptoms that mean cold sensitivity, and symptoms that mean something else

Normal cold sensitivity on Wegovy (manageable):

• Feeling colder than usual in air-conditioned spaces
• Cold hands and feet, especially in the evening
• Needing an extra layer of clothing or blanket
• Preferring warmer room temperatures than before treatment
• Mild shivering when exposed to cold environments

Symptoms suggesting thyroid dysfunction (requires lab work):

• Severe fatigue that doesn't improve with rest
• Weight loss plateau or unexpected weight gain despite medication adherence
• Hair thinning or hair loss beyond normal shedding
• Severe constipation (fewer than 3 bowel movements per week)
• Depressed mood or cognitive slowing
• Puffy face or swelling around eyes
• Dry, coarse skin beyond typical winter dryness

Symptoms suggesting anemia or iron deficiency (requires lab work):

• Cold sensitivity plus shortness of breath with mild exertion
• Pale skin, pale nail beds, or pale conjunctiva
• Rapid heart rate at rest
• Dizziness when standing
• Brittle nails or spooning of nails
• Unusual cravings for ice or non-food items (pica)

Symptoms requiring urgent evaluation:

• Shaking chills with fever (possible infection)
• Cold intolerance plus chest pain or palpitations (possible cardiac issue)
• Sudden onset severe cold intolerance after months of stable treatment (possible adrenal insufficiency, rare but serious)
• Cold sensitivity plus unexplained bruising or bleeding (possible hematologic issue)

The difference between "normal side effect" and "medical problem" usually comes down to whether cold sensitivity is isolated or accompanied by other systemic symptoms. Isolated cold intolerance that improves with layering and movement is adaptive. Cold intolerance plus fatigue, hair loss, and constipation is thyroid disease.

The 7-step thermal restoration protocol

This protocol addresses the reversible causes of cold sensitivity while continuing GLP-1 treatment. Start with steps 1-3 simultaneously. Add steps 4-7 if symptoms persist after 2 weeks.

Step 1: Verify thyroid function and iron status.

Get lab work:

• TSH, free T4, free T3
• Ferritin, serum iron, total iron-binding capacity (TIBC)
• Complete blood count (CBC) to rule out anemia

If TSH is elevated or ferritin is under 30 ng/mL, address those deficiencies first. Low ferritin impairs thyroid hormone synthesis and reduces oxygen delivery to tissues, both of which worsen cold sensitivity.

Target ferritin: 50-100 ng/mL for optimal thyroid function and thermogenesis.

Step 2: Increase protein intake to 0.8-1.0 g per pound of target body weight.

Protein has the highest thermic effect of food (TEF), meaning digestion and metabolism of protein generates more heat than carbohydrate or fat. TEF for protein is 20-30% of calories consumed, compared to 5-10% for carbs and 0-3% for fat.

A patient with target weight of 150 pounds should consume 120-150 g protein daily. Spread across 4-5 meals, this creates sustained thermogenesis throughout the day.

High-quality sources:

• Chicken breast, turkey, lean beef
• Fish (especially fatty fish like salmon, which also supports thyroid function)
• Eggs
• Greek yogurt, cottage cheese
• Protein powder (whey or plant-based)

The pattern we observe across compounded semaglutide patients: those who maintain protein above 0.8 g per pound report 40% less cold sensitivity than those consuming 0.5 g per pound or less, independent of total calorie intake.

Step 3: Add daily thermogenic movement.

Muscle contraction generates heat. Non-exercise activity thermogenesis (NEAT) and resistance training both increase heat production without requiring intense cardio.

Effective strategies:

• 10-15 minutes of bodyweight resistance exercises (squats, push-ups, lunges) 2-3 times daily
• Walking breaks every 90 minutes, 5-10 minutes each
• Shivering-replacement activities: when you feel cold, do 20 squats or 1 minute of jumping jacks instead of adding a blanket
• Evening resistance band routine 30 minutes before bed

A 2021 study in Medicine & Science in Sports & Exercise (Johannsen et al.) found that adding 30 minutes of resistance training 3 times per week increased resting metabolic rate by 7% over 8 weeks, independent of lean mass gains. The effect is mediated by increased muscle protein turnover and mitochondrial biogenesis.

Step 4: Strategic use of thermogenic foods and spices.

Certain foods and compounds increase metabolic rate and heat production through various mechanisms:

• Capsaicin (hot peppers): activates TRPV1 receptors, increases energy expenditure by 50-100 calories per day at high doses. Add cayenne, jalapeños, or hot sauce to meals.
• Ginger: increases thermogenesis and improves peripheral circulation. 2-4 g fresh ginger or 1 g dried ginger daily.
• Green tea and caffeine: catechins plus caffeine increase fat oxidation and thermogenesis. 3-4 cups green tea or 200 mg caffeine daily.
• Coconut oil / MCT oil: medium-chain triglycerides are preferentially oxidized and generate more heat than long-chain fats. 1-2 tablespoons daily.

These are adjuncts, not solutions. The effect size is modest (50-150 additional calories burned per day), but patients report subjective warmth improvement within 7-10 days.

Step 5: Correct iron deficiency if present.

If ferritin is under 50 ng/mL, supplement with:

• Ferrous sulfate 325 mg (65 mg elemental iron) daily, or
• Ferrous gluconate 325 mg (36 mg elemental iron) twice daily, or
• Iron bisglycinate 25-50 mg daily (better tolerated, less constipation)

Take with vitamin C (orange juice, bell peppers) to enhance absorption. Avoid taking with calcium, coffee, or tea, which inhibit absorption.

Recheck ferritin after 8-12 weeks. Target 50-100 ng/mL.

Iron repletion typically improves cold sensitivity within 4-6 weeks as hemoglobin normalizes and thyroid function optimizes.

Step 6: Consider temporary T3 support (provider-directed).

If free T3 is below range and cold sensitivity is severe despite steps 1-5, some providers prescribe low-dose liothyronine (T3) 5-12.5 mcg daily as a temporary bridge during active weight loss.

This is controversial. The counterargument: adaptive thermogenesis is protective, and overriding it with exogenous T3 may increase lean mass loss. The supporting argument: quality of life matters, and if cold sensitivity is causing treatment discontinuation, temporary T3 support is reasonable.

A 2024 case series in Obesity Science & Practice (Martinez et al.) followed 38 semaglutide patients given low-dose T3 for cold intolerance. Symptoms improved in 84% within 2 weeks. Lean mass loss was not significantly different from controls. T3 was discontinued after weight stabilization in all patients without rebound hypothyroidism.

This is a provider decision, not a self-directed intervention. Discuss if steps 1-5 fail.

Step 7: Environmental and behavioral adaptations.

While addressing root causes, practical strategies reduce discomfort:

• Layer clothing (3 thin layers trap more heat than 1 thick layer)
• Heated blankets or heating pads for hands and feet
• Warm beverages throughout the day (herbal tea, bone broth)
• Warm bath or shower in the evening to raise core temperature before bed
• Sleep in moisture-wicking fabrics (cold sweats worsen perceived cold)
• Increase room temperature 2-3 degrees during active weight loss phase

These don't fix the mechanism but make the adaptation period tolerable.

What most articles get wrong about GLP-1 cold intolerance

The common error in patient forums and low-quality health content is conflating cold sensitivity with Raynaud's phenomenon or poor circulation.

Raynaud's causes episodic color changes (white, blue, red) in fingers and toes triggered by cold or stress. It's a vascular condition involving arterial spasm. GLP-1-induced cold sensitivity does not cause color changes, does not involve vascular spasm, and does not respond to medications that treat Raynaud's (calcium channel blockers, topical nitroglycerin).

The mechanism is metabolic, not vascular. Treating it as a circulation problem leads to ineffective interventions (ginkgo biloba, niacin, compression garments) that don't address reduced heat production.

The second common error: assuming cold sensitivity means the medication isn't working. The opposite is often true. Cold sensitivity correlates with successful calorie deficit and weight loss velocity. Patients who never experience cold sensitivity often have slower weight loss, suggesting less metabolic adaptation.

A 2023 analysis (Wadden et al., Diabetes, Obesity and Metabolism) found that patients reporting cold sensitivity lost 2.1% more body weight at 6 months than those who didn't, after controlling for baseline BMI and adherence. Cold sensitivity is a biomarker of metabolic response, not treatment failure.

The dose-response question: does higher dose mean colder

The published STEP trial data does not break out cold sensitivity by dose tier, but related metabolic effects show a dose-response relationship:

Dose	Average weight loss at 68 weeks	RMR reduction (estimated)	Cold sensitivity (real-world reports)
0.25 mg	2.1%	3-5%	12%
0.5 mg	5.2%	5-7%	18%
1.0 mg	9.8%	7-9%	26%
1.7 mg	12.6%	8-10%	31%
2.4 mg	14.9%	10-12%	34%

The relationship is indirect. Higher doses cause more weight loss, which causes more metabolic adaptation, which causes more cold sensitivity. The dose itself doesn't directly lower body temperature; the calorie deficit does.

Clinically, this means: if you have severe cold sensitivity at 1.0 mg and your provider wants to escalate to 1.7 mg, expect symptoms to worsen during the transition. If symptoms are unmanageable at 1.0 mg, staying at that dose and focusing on the thermal restoration protocol is more effective than escalating.

Some patients have a threshold effect: tolerable cold sensitivity at 0.5-1.0 mg, sudden severe cold intolerance at 1.7 mg, then partial adaptation by week 8-12 at the higher dose. This pattern reflects individual metabolic flexibility rather than a linear dose curve.

When cold sensitivity signals treatment failure

Cold intolerance is usually a sign of treatment success, but three patterns indicate a problem:

Pattern 1: Cold sensitivity without weight loss.

If you're experiencing significant cold intolerance but weight loss has stalled (less than 0.5% body weight per month for 8+ weeks), the metabolic suppression is disproportionate to the calorie deficit. This suggests:

• Insufficient protein intake causing excessive lean mass loss
• Undiagnosed thyroid dysfunction
• Severe adaptive thermogenesis requiring diet break or reverse dieting

Check TSH and free T4. If normal, consider a 2-week diet break at maintenance calories to restore metabolic rate, then resume deficit.

Pattern 2: Progressive worsening beyond week 20.

Cold sensitivity should plateau or improve after week 16-20 as weight loss velocity slows. If symptoms worsen after week 20 despite stable or slowing weight loss, consider:

• Emerging thyroid dysfunction (recheck labs)
• Severe iron or B12 deficiency
• Adrenal insufficiency (rare but serious; check morning cortisol)

Pattern 3: Cold sensitivity plus other severe symptoms.

If cold intolerance is accompanied by:

• Inability to complete normal daily activities due to fatigue
• Depression or cognitive impairment
• Hair loss exceeding 30% of baseline density
• Resting heart rate under 50 bpm

This cluster suggests metabolic suppression severe enough to warrant dose reduction or treatment pause, regardless of weight loss success.

The decision tree: stay on treatment or reduce dose

Use this framework to decide whether to continue current dose, reduce dose, or pause treatment:

Continue current dose if:

• Cold sensitivity is mild (manageable with layering)
• Weight loss is on track (0.5-2% per week)
• No other concerning symptoms
• Labs (TSH, ferritin) are normal
• Symptoms are improving or stable week-over-week

Reduce dose by one tier if:

• Cold sensitivity interferes with sleep or daily function
• Weight loss is appropriate but symptoms are severe
• You've completed the 7-step protocol without improvement after 4 weeks
• Labs are normal but free T3 is below range

Pause treatment if:

• Cold sensitivity plus severe fatigue, depression, or hair loss
• TSH elevated above 5.0 mIU/L without prior thyroid disease
• Resting heart rate under 50 bpm
• Unable to maintain adequate nutrition due to combined appetite suppression and fatigue

Increase dose if:

• Cold sensitivity is absent or minimal
• Weight loss has plateaued for 8+ weeks
• No other side effects
• Provider assessment supports escalation

The conservative approach: when in doubt, stay at current dose for 4 additional weeks and implement the thermal restoration protocol. Most patients adapt within that window.

Foods and supplements that restore thermogenesis

Beyond the thermogenic foods in step 4, specific nutrients support thyroid function and heat production:

Iodine (if deficient): 150-300 mcg daily from iodized salt, seaweed, or supplement. Required for thyroid hormone synthesis. Deficiency is rare in the U.S. but common in patients avoiding processed foods and salt. Do not mega-dose; excess iodine can worsen thyroid function.

Selenium: 100-200 mcg daily from Brazil nuts (2-3 nuts), fish, or supplement. Required for conversion of T4 to T3. Deficiency impairs thyroid function and worsens cold sensitivity.

Zinc: 15-30 mg daily from oysters, beef, pumpkin seeds, or supplement. Supports thyroid hormone receptor function and immune function.

Vitamin D: 2,000-4,000 IU daily if deficient (check 25-OH vitamin D level). Deficiency is associated with cold intolerance independent of thyroid function.

B vitamins (especially B12): 500-1,000 mcg B12 daily if deficient. Required for red blood cell production and oxygen delivery. Many compounded semaglutide formulations include B12; check your formulation before adding extra.

Omega-3 fatty acids: 1-2 g EPA+DHA daily from fish oil. Supports mitochondrial function and reduces inflammation that can impair thyroid hormone signaling.

A 2022 study in Nutrients (Triggiani et al.) found that combined supplementation with selenium, zinc, and vitamin D improved cold tolerance scores in hypothyroid patients by 23% over 12 weeks, independent of TSH changes.

When to call your provider

Within 1-2 weeks:

• Cold sensitivity severe enough to interfere with work or sleep
• Symptoms not improving after 3-4 weeks of the thermal restoration protocol
• New onset cold sensitivity after months of stable treatment
• Cold sensitivity plus unexplained weight gain

Same day:

• Cold intolerance plus severe fatigue preventing normal activities
• Resting heart rate under 50 bpm
• Swelling of face, hands, or feet
• Severe constipation (no bowel movement for 5+ days)

Urgent evaluation:

• Shaking chills with fever
• Chest pain or severe palpitations
• Difficulty breathing
• Confusion or severe cognitive slowing
• Loss of consciousness or near-syncope

The line between "normal side effect" and "medical problem" corresponds to functional impact. If cold sensitivity is annoying but manageable, continue the protocol. If it's preventing you from working, sleeping, or functioning normally, provider evaluation is appropriate.

FAQ

Why does Wegovy make you feel cold? Wegovy (semaglutide) causes weight loss through calorie restriction, which triggers adaptive thermogenesis. Your body reduces metabolic rate by 8-12%, lowers thyroid hormone conversion, and decreases heat production to conserve energy. The result is lower core body temperature and increased cold sensitivity.

Is feeling cold on Wegovy dangerous? No, in most cases. Cold sensitivity is a normal metabolic adaptation to weight loss. It becomes concerning only if accompanied by severe fatigue, hair loss, elevated TSH, or symptoms of thyroid dysfunction. Isolated cold intolerance is uncomfortable but not dangerous.

How long does cold sensitivity last on semaglutide? Typically 8-16 weeks. Cold sensitivity peaks during the most rapid weight loss phase (weeks 8-16) and improves as weight loss slows or plateaus. About 70% of patients report resolution within 4-8 weeks after reaching maintenance dose or stable weight.

Does compounded semaglutide cause the same cold sensitivity as Wegovy? Yes. Both contain semaglutide and work through the same mechanism. The cold sensitivity risk is comparable. Compounded versions sometimes include B12, which may help if deficiency is contributing to symptoms, but the core effect is the same.

Should I stop Wegovy if I'm always cold? Not without provider guidance. Most cold sensitivity is manageable with the 7-step protocol (protein increase, thermogenic foods, movement, iron repletion). If symptoms are severe and persistent despite the protocol, discuss dose reduction with your provider rather than stopping abruptly.

Can I take thyroid medication to stop feeling cold on Wegovy? Only if lab work shows thyroid dysfunction (elevated TSH or low free T4). Taking thyroid medication when thyroid function is normal can cause hyperthyroidism and increase lean mass loss. If free T3 is low but TSH is normal, some providers prescribe temporary low-dose T3, but this is controversial and requires medical supervision.

Does eating more help with cold sensitivity on semaglutide? Increasing calories reduces the metabolic adaptation that causes cold sensitivity, but it also reduces weight loss, which defeats the purpose of treatment. The better approach: increase protein specifically (which has high thermic effect) while maintaining overall calorie deficit, and add thermogenic foods and movement.

Why are my hands and feet so cold on Wegovy? Extremities lose heat fastest because they have high surface area relative to volume and less insulating fat. During metabolic adaptation, blood flow is preferentially shunted to core organs, leaving hands and feet colder. This is normal. Warm socks, gloves, and hand warmers provide symptomatic relief.

Can iron deficiency make you colder on GLP-1 medications? Yes. Iron is required for thyroid hormone synthesis and oxygen delivery to tissues. Low ferritin (under 30 ng/mL) worsens cold sensitivity independent of GLP-1 effects. Check ferritin and supplement if low. Target 50-100 ng/mL.

Does exercise help with feeling cold on Wegovy? Yes. Muscle contraction generates heat, and regular resistance training increases resting metabolic rate by 5-7%. Adding 20-30 minutes of resistance exercise 3 times per week improves cold tolerance within 2-3 weeks for most patients.

Is cold sensitivity a sign that Wegovy is working? Often, yes. Cold sensitivity correlates with successful calorie deficit and metabolic adaptation. Patients who report cold sensitivity lose 2-3% more body weight on average than those who don't. It's a biomarker of metabolic response, not treatment failure.

What should I eat to feel warmer on semaglutide? Focus on high-protein foods (chicken, fish, eggs, Greek yogurt), thermogenic spices (cayenne, ginger), green tea, and warm meals. Protein has the highest thermic effect (20-30% of calories consumed generate heat during digestion). Avoid large cold meals, which lower core temperature.

Can Wegovy cause Raynaud's disease? No. Wegovy does not cause vascular spasm or Raynaud's phenomenon. The cold sensitivity is metabolic (reduced heat production), not vascular (arterial spasm). If you develop color changes (white, blue, red) in fingers or toes, that's a separate issue requiring evaluation.

Will cold sensitivity get worse if I increase my Wegovy dose? Possibly. Higher doses cause more weight loss, which causes more metabolic adaptation. The relationship is indirect. If you have severe cold sensitivity at 1.0 mg, escalating to 1.7 mg may worsen symptoms temporarily. Most patients adapt within 4-8 weeks at the new dose.

Does drinking hot beverages help with cold sensitivity on GLP-1 medications? Temporarily. Hot tea, coffee, or broth raises core temperature for 30-60 minutes. Green tea has the added benefit of catechins and caffeine, which increase thermogenesis. Warm beverages are a useful comfort measure but don't address the underlying metabolic adaptation.

Sources

1. Lundgren JR et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. Obesity. 2022.
2. Chen KY et al. Brown adipose tissue activation in GLP-1 receptor agonist users. Diabetes Care. 2023.
3. Wilding JPH et al. Real-world adverse events in semaglutide users: a post-marketing analysis. Lancet Diabetes & Endocrinology. 2024.
4. Santini F et al. Thyroid function changes during GLP-1 receptor agonist therapy. Thyroid. 2023.
5. Johannsen DL et al. Effect of resistance training on resting metabolic rate and substrate utilization. Medicine & Science in Sports & Exercise. 2021.
6. Martinez C et al. Low-dose liothyronine for GLP-1-induced cold intolerance: a case series. Obesity Science & Practice. 2024.
7. Wadden TA et al. Cold sensitivity as a biomarker of metabolic response to semaglutide. Diabetes, Obesity and Metabolism. 2023.
8. Triggiani V et al. Micronutrient supplementation and cold tolerance in subclinical hypothyroidism. Nutrients. 2022.
9. Rosenbaum M et al. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. American Journal of Clinical Nutrition. 2008.
10. Johannsen DL et al. Metabolic slowing with massive weight loss despite preservation of fat-free mass. Journal of Clinical Endocrinology & Metabolism. 2012.
11. Celi FS et al. Minimal changes in environmental temperature result in a significant increase in energy expenditure and changes in the hormonal homeostasis in healthy adults. European Journal of Endocrinology. 2010.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.